IASLC Lung Cancer News (ILCN), October 2022
ILCN | English
Image For Activity Cover
Availability
On-Demand
Cost
$0.00
Credit Offered
No Credit Offered
Table of Contents
  • Growing Body of Evidence Highlights Potential Applications for Liquid Biopsy in Clinical Practice
  • IASLC Leadership Shares Experiences, Offers Advice for Women in Thoracic Oncology
  • When Perfect is the Enemy of Good: Investigators Compare Rigorous Clinical Trial Data to Real-World Experience
  • Public Interest in Complementary, Alternative Approaches to Smoking Cessation Growing
  • In Brief for Oct. 26, 2022
  • NACLC 22 Educational Session Explores the Rationale for Immune Checkpoint Inhibition
  • Researcher Reveals How Air Pollution May Cause Lung Cancer
  • In Brief for October 12, 2022
  • KEYNOTE-604 Follow-Up Results Continue to Show Clinically Meaningful Improvement
  • Study Shows Shorter-Term Assessments Underestimate Pollution Exposure
  • POSEIDON Analysis Shows Sustained Benefit with Triplet Regimen Regardless of Mutational Status
IASLC Lung Cancer News (ILCN) is the offical news source of the only global association dedicated to the multidisciplinary study of lung cancer, published bimonthly by the International Association for the Study of Lung Cancer (IASLC). 

Click here to link to Submission Guidelines.
Powered By